Physician profile
Keyur N Patel
NPI 1770543803
$1,096.49
in general payments reported to CMS, 2019-2025
19 companies · $133 in 2025
The $133 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $230 · 2020: $160 · 2021: $77.47 · 2022: $13.05 · 2023: $286 · 2024: $197 · 2025: $133.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $616.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $616.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $170.04 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Kestra Medical Technology Services, INC. | $139.01 | 2024-2025 | Assure Wcd |
| Abbott Laboratories | $137.17 | 2023 | Perclose Proglide |
| Glaxosmithkline, LLC. | $107.10 | 2023 | |
| Gilead Sciences, INC. | $89.78 | 2020 | |
| Welch Allyn | $77.47 | 2021 | |
| Astellas Pharma US INC | $64.89 | 2019 | |
| Novo Nordisk INC | $64.22 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $62.90 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $28.24 | 2019-2020 | |
| Catalyst Pharmaceuticals, INC. | $24.18 | 2023 | Fycompa |
| Mylan Specialty L.P. | $21.44 | 2020 | |
| Csl Behring | $21.40 | 2025 | Hizentra |
| Redhill Biopharma INC. | $18.18 | 2020 | |
| Reprise Biomedical, INC. | $17.46 | 2023 | Miro3d |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $15.80 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.27 | 2019 | |
| Amgen INC. | $13.05 | 2022 | |
| Merck Sharp & Dohme LLC | $10.89 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keyur Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.